Personalized Medicine for Mental Health Treatment
Develop a platform that combines various data sources and utilizes artificial intelligence to provide personalized treatment plans for mental health disorders. The platform would analyze genetic, lifestyle, and environmental factors to offer tailored medications and therapy options, increasing treatment efficacy.Market size: The global mental health pharmaceutical market is projected to reach $148 billion by 2026, with a compound annual growth rate of 2.9%.Tags: mental health, personalized medicine, pharmaceuticals, artificial intelligence, data analysis, treatment plans, genetics,Country: United States, Canada, United Kingdom, Germany, Australia,Industry: Pharmaceuticals,Category: Mental Health,Customer total: 450 million
Pharmaceuticals
United States
